Good morning :)
Place Order
Add to Watchlist

Samsrita Labs Ltd

SAMSRITA

Samsrita Labs Ltd

SAMSRITA
Health CareLife Sciences Tools & Services
SmallcapWith a market cap of ₹32 cr, stock is ranked 3,829
High RiskStock is 4.67x as volatile as Nifty
23.962.97% (+0.69)
23.962.97% (+0.69)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CareLife Sciences Tools & Services
SmallcapWith a market cap of ₹32 cr, stock is ranked 3,829
High RiskStock is 4.67x as volatile as Nifty

How to use scorecard? Learn more

Health CareLife Sciences Tools & Services
SmallcapWith a market cap of ₹32 cr, stock is ranked 3,829
High RiskStock is 4.67x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-131.322.68
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.116.510.52%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Dr Habeebullah Life Sciences Ltd is engaged in the business of bio-pharma. It is focused on new drug discovery; clinical research organization related activities; stem cell-lab, research & therapy; nutraceuticals product development etc.

Peers

Hmm, looks like data is unavailable here. Please come back after some time
Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue3.741.290.632.011.590.161.930.310.00
Raw Materialssubtract3.731.240.000.000.000.000.020.020.000.25
Power & Fuel Costsubtract0.010.020.370.310.250.000.000.00
Employee Costsubtract0.220.711.481.400.330.110.130.13
Selling & Administrative Expensessubtract0.350.802.131.480.260.090.060.06
Operating & Other expensessubtract0.040.190.370.430.080.200.800.06
Depreciation/Amortizationsubtract0.000.010.010.020.020.010.010.000.00
Interest & Other Itemssubtract0.000.000.000.010.010.000.000.000.00
Taxes & Other Itemssubtract0.000.72-0.06-0.03-0.070.000.010.000.01
EPS0.03-1.27-0.94-1.83-1.39-0.521.01-0.47-0.18-0.17
DPS0.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

Peers & Comparison

Hmm, looks like data is unavailable here. Please come back after some time.

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding52.87%0.00%0.00%0.00%47.13%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

SAMSRITA has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Earnings
Samsrita Labs reports standalone net loss of Rs 0.04 crore in the September 2024 quarter

Net Loss of Samsrita Labs reported to Rs 0.04 crore in the quarter ended September 2024 as against net loss of Rs 0.05 crore during the previous quarter ended September 2023. There were no Sales reported in the quarter ended September 2024 and during the previous quarter ended September 2023.Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
Samsrita Labs to conduct board meeting

Samsrita Labs will hold a meeting of the Board of Directors of the Company on 11 November 2024Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Samsrita Labs to hold AGM

Samsrita Labs announced that the 28th Annual General Meeting (AGM) of the company will be held on 21 September 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live
Earnings
Samsrita Labs reports standalone net loss of Rs 0.09 crore in the June 2024 quarter

Net Loss of Samsrita Labs reported to Rs 0.09 crore in the quarter ended June 2024 as against net loss of Rs 0.09 crore during the previous quarter ended June 2023. There were no Sales reported in the quarter ended June 2024 and during the previous quarter ended June 2023.Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Samsrita Labs to announce Quarterly Result

Samsrita Labs will hold a meeting of the Board of Directors of the Company on 12 August 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live

Dr Habeebullah Life Sciences reports standalone net profit of Rs 1.58 crore in the March 2022 quarter

2 years agoBusiness Standard

Dr Habeebullah Life Sciences reports standalone net loss of Rs 0.04 crore in the June 2021 quarter

3 years agoBusiness Standard

Dr Habeebullah Life Sciences reports consolidated net loss of Rs 0.04 crore in the June 2021 quarter

3 years agoBusiness Standard

Dr Habeebullah Life Sciences reports standalone net loss of Rs 0.02 crore in the March 2021 quarter

3 years agoBusiness Standard

Dr Habeebullah Life Sciences reports consolidated net loss of Rs 0.01 crore in the March 2021 quarter

3 years agoBusiness Standard